Michael Mano - Feb 28, 2025 Form 4 Insider Report for Karyopharm Therapeutics Inc. (KPTI)

Role
SVP, General Counsel&Secretary
Signature
/s/Nancy Smith as Attorney-in-Fact for Michael Mano
Stock symbol
KPTI
Transactions as of
Feb 28, 2025
Transactions value $
$0
Form type
4
Date filed
3/4/2025, 04:46 PM
Previous filing
Sep 5, 2024
Next filing
Mar 6, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KPTI Common Stock Award $0 +3.33K +18.26% $0.00 21.6K Feb 28, 2025 Direct F1, F2
transaction KPTI Common Stock Award $0 +2.25K +10.42% $0.00 23.8K Feb 28, 2025 Direct F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KPTI Stock Option (right to buy) Award $0 +6.67K $0.00 6.67K Feb 28, 2025 Common Stock 6.67K $7.95 Direct F2, F4
transaction KPTI Stock Option (right to buy) Award $0 +4.5K $0.00 4.5K Feb 28, 2025 Common Stock 4.5K $7.95 Direct F2, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the award of restricted stock units ("RSUs") pursuant to the Karyopharm Therapeutics Inc. 2022 Equity Incentive Plan, as amended (the "2022 Plan"). RSUs convert into Karyopharm Therapeutics Inc. common stock on a one-for-one basis. The RSUs vest in three equal annual installments beginning February 28, 2026.
F2 Amounts reported in this Form 4 reflect the one-for-fifteen reverse stock split effected by the Issuer on February 25, 2025.
F3 Represents the award of RSUs pursuant to the 2022 Plan. RSUs convert into Karyopharm Therapeutics Inc. common stock on a one-for-one basis. The RSUs vest in two equal annual installments beginning February 28, 2026.
F4 This option was granted on February 28, 2025 pursuant to the 2022 Plan. The shares underlying this option vest as to 25% of the shares on February 28, 2026, with the remaining 75% vesting in 36 equal monthly installments thereafter.